Streetbeat News

Stock Prices

XMRUSD

Monero's (XMR) price has increased by 4.15% to $161.92 within the past 24 hours, despite a 1.0% loss over the past week. The coin's trading volume has decreased by 4.0% while its circulating supply has risen by 0.43%, bringing the total to 18.45 million. Monero's current market cap is $2.99 billion, ranking it #31.

Portfolio Pulse from Benzinga Insights

August 02, 2024 | 3:02 pm

ESAB

ESAB shares are trading lower after the company reported Q2 financial results and cut its FY24 core revenue growth guidance.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 3:02 pm

OMI

Owens & Minor shares are trading lower following the company's Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 3:01 pm

ARDX

Six analysts have provided mixed ratings for Ardelyx (NASDAQ: ARDX) over the past quarter, with a majority being somewhat bullish. The average 12-month price target is now $12.0, down from $13.20 previously. Key analysts have maintained their ratings, with some lowering their price targets. Ardelyx has shown significant revenue growth but faces challenges with high debt and low returns on equity and assets.

Portfolio Pulse from Benzinga Insights

August 02, 2024 | 3:01 pm

LTCUSD

Litecoin (LTC) has fallen 3.66% in the past 24 hours to $65.92, continuing a week-long decline of 4%. Trading volume increased by 13% over the week, while circulating supply rose slightly. Litecoin's market cap is $4.94 billion, ranking it #23.

Portfolio Pulse from Benzinga Insights

August 02, 2024 | 3:01 pm

AVB

In the past three months, 13 analysts have rated AvalonBay Communities (NYSE:AVB) with a mix of bullish to bearish sentiments. The average 12-month price target has increased to $214.0, with a high of $255.00 and a low of $194.00. Recent analyst actions have predominantly been upgrades, reflecting positive sentiment towards the company's financial performance and market position.

Portfolio Pulse from Benzinga Insights

August 02, 2024 | 3:01 pm

VIR

Six analysts have provided mixed ratings for Vir Biotechnology (NASDAQ:VIR) in the latest quarter. The average 12-month price target is $65.33, with a high of $110.00 and a low of $15.00. Recent analyst actions include rating upgrades and maintained ratings, reflecting evolving sentiments.

Portfolio Pulse from Benzinga Insights

August 02, 2024 | 3:01 pm

JPM

JPMorgan Chase (NYSE:JPM) has outperformed the market over the past 10 years with an average annual return of 13.59%, resulting in a $100 investment growing to $355.70. The article highlights the impact of compounded returns on investment growth.

Portfolio Pulse from Benzinga Insights

August 02, 2024 | 3:00 pm

FRT

Over the past three months, five analysts have shared their insights on Federal Realty Investment (NYSE:FRT), with ratings ranging from bullish to bearish. The average 12-month price target has increased by 3.57% to $116.2. Analysts have recently adjusted their ratings and price targets, reflecting a positive shift in sentiment.

Portfolio Pulse from Benzinga Insights

August 02, 2024 | 3:00 pm

KLAC

KLA (NASDAQ:KLAC) has significantly outperformed the market over the past 10 years, delivering an average annual return of 25.56%. A $100 investment in KLAC 10 years ago would be worth $970.19 today. The article highlights the power of compounded returns.

Portfolio Pulse from Benzinga Insights

August 02, 2024 | 3:00 pm